TET2 and acute myeloid leukemia: In concordance with our AML cell line data, Tet2/Stag2-mutant bone marrow cells exhibited higher levels of dsDNA breaks and increased sensitivity to treatment with talazoparib when cultured in vitro (Supplemental Figure 3, E–G).